Want to see RYAN full AI Analyst Report?
Ryan Specialty Group (RYAN) AI Stock Analysis
Ryan Specialty Group
(NYSE:RYAN)
The score is held back primarily by elevated and rising leverage despite solid growth and cash generation. Technicals are supportive with a clear uptrend, while valuation is a notable headwind due to a high P/E. The latest earnings call was constructive (steady organic-growth outlook and improved margin view), but competitive and pricing pressures temper the outlook.
Ryan Specialty Group Key Performance Indicators (KPIs)
Revenue by GeographyShows where sales are generated across regions or countries, highlighting market concentration and expansion opportunities. For Ryan, geographic splits signal exposure to local insurance markets, regulatory environments, and currency effects — high concentration raises country-specific risk, while broader geographic mix can indicate more resilient growth prospects.
U.S. revenue is the clear engine—steady growth with pronounced Q2 spikes tied to property renewals—so the company’s near-term top‑line and margins are vulnerable to the large property rate declines management warned about (25–35%), especially in Q2; foreign revenue is tiny but growing faster percentage‑wise, offering incremental geographic diversification (and Ryan Re momentum) that could partially offset U.S. property pressure over time. Watch Q2 organic trends and how M&A/Empower savings are deployed to shore up margins as pricing softens.
The FlyRyan Specialty Group (RYAN) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $5.55B
- Dividend Yield
- 1.12%
- Average Volume (3M)
- 1.88M
- Price to Earnings (P/E)
- 45.0
- Beta (1Y)
- 0.50
- Revenue Growth
- 9.26%
- EPS Growth
- 51.29%
- Country
- US
- Employees
- 6,110
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Insurance - Brokers
Ryan Specialty Group Business Overview & Revenue Model
Company Description
Ryan Specialty Holdings, Inc. functions as a provider of specialized insurance products and comprehensive solutions for the benefit of insurance brokers, agents, and carriers. The company delivers a range of services including distribution, underwrit...
How the Company Makes Money
Ryan Specialty primarily makes money by earning insurance distribution and underwriting-related revenues tied to insurance premium volume it helps place or manage. Key revenue streams include: (1) Wholesale brokerage/distribution: Through its wholesa...
Ryan Specialty Group Earnings Call Summary
The call was positive overall. Management reported continued revenue, earnings, organic growth, capital-return, talent, and AI execution momentum despite intensifying property and casualty pricing pressure, broader competition, normalized construction growth, transactional-liability uncertainty, and builders' risk softness. The company improved its 2026 margin outlook, maintained organic-growth guidance toward the higher end of its mid-single-digit range, and expressed confidence in its structural market position and long-term growth opportunities.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For 2026, management continues to guide to organic revenue growth toward the higher end of its mid-single-digit range, with a full year adjusted EBITDAC margin that will be down modestly year-over-year; the adjusted effective tax rate was approximately 26%, with a similar rate expected in the fourth quarter, and GAAP interest expense net of interest income on operating funds is expected to be approximately $59 million in the fourth quarter. Guidance embeds continued property pricing declines, heightened competition during the fourth quarter, our second largest property quarter, casualty competition broadened beyond small commercial and middle market and into pockets of higher hazard classes, a more normalized level of growth in construction projects, intensified competition from new facilities as well as the admitted market impacting binding authority, more moderate growth in transactional liability and continued softness in builders' risk. Management said it continues to expect modest margin expansion in most years, but is not providing any specific guidance for 2027.
Ryan Specialty Group Financial Statement Overview
Summary
Strong revenue growth and consistently positive free cash flow support operating quality, but the balance sheet is a material risk: leverage is high and rising (debt-to-equity up to ~8.6x TTM), reducing financial flexibility and raising sensitivity to earnings/credit conditions.
Income Statement
74PositiveBalance Sheet
38NegativeCash Flow
76Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.25B | 3.05B | 2.52B | 2.08B | 1.73B | 1.43B |
| Gross Profit | 2.56B | 2.76B | 2.52B | 2.08B | 1.73B | 1.43B |
| EBITDA | 819.54M | 803.08M | 598.63M | 473.27M | 393.31M | 253.60M |
| Net Income | 245.01M | 63.40M | 94.67M | 61.04M | 61.05M | 65.87M |
Balance Sheet | ||||||
| Total Assets | 11.04B | 10.56B | 9.65B | 7.25B | 6.38B | 5.46B |
| Cash, Cash Equivalents and Short-Term Investments | 168.81M | 158.32M | 554.14M | 838.79M | 992.72M | 386.96M |
| Total Debt | 3.86B | 3.53B | 3.46B | 2.16B | 2.16B | 1.68B |
| Total Liabilities | 10.14B | 9.31B | 8.55B | 6.27B | 5.57B | 4.86B |
| Stockholders Equity | 446.71M | 648.07M | 627.66M | 559.75M | 478.40M | 343.77M |
Cash Flow | ||||||
| Free Cash Flow | 500.67M | 575.71M | 467.87M | 447.43M | 320.47M | 263.71M |
| Operating Cash Flow | 570.18M | 643.67M | 514.87M | 477.20M | 335.51M | 273.49M |
| Investing Cash Flow | -157.28M | -834.01M | -1.76B | -476.23M | -22.42M | -457.94M |
| Financing Cash Flow | -8.01M | 78.12M | 1.17B | -12.61M | 314.76M | 429.28M |
Ryan Specialty Group Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RYAN, the sentiment is Positive. The current price of 45.12 is above the 20-day moving average (MA) of 41.04, above the 50-day MA of 40.47, and above the 200-day MA of 38.78, indicating a bullish trend. The MACD of 1.36 indicates Negative momentum. The RSI at 67.04 is Neutral, neither overbought nor oversold. The STOCH value of 80.10 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RYAN.
Ryan Specialty Group Risk Analysis
Ryan Specialty Group disclosed 74 risk factors in its most recent earnings report. Ryan Specialty Group reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
1 New RiskRyan Specialty Group Peers Comparison
Overall Rating
AMSF68Neutral- RYAN64Neutral
TIPT59Neutral
EIG52Neutral
JRVR47Neutral
OSG39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| AMSF | 68Neutral | $387.59M | 9.58 | 16.38% | 12.66% | 7.68% | -17.65% |
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| RYAN | 64Neutral | $11.16B | 44.96 | 34.57% | 1.12% | 9.26% | 51.29% |
| TIPT | 59Neutral | $620.69M | 1.69 | 58.47% | 1.36% | -99.24% | -244.16% |
| EIG | 52Neutral | $804.09M | 27.16 | 3.17% | 2.86% | -12.95% | -33.09% |
| JRVR | 47Neutral | $178.98M | 7.95 | 4.68% | 1.01% | -1.82% | ― |
| OSG | 39Underperform | $227.06M | -1.43 | -18.99% | ― | 7.99% | -698.73% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| RYAN | Ryan Specialty Group Holdings, Inc. Class A | 45.48 | -8.86 | -16.30% | |
| AMSF | AMERISAFE, Inc. | 20.70 | -16.42 | -44.23% | |
| EIG | Employers Holdings | 46.17 | 9.79 | 26.92% | |
| OSG | Octave Specialty Group, Inc. | 5.20 | -3.07 | -37.12% | |
| TIPT | Tiptree Financial Inc | 17.59 | -0.45 | -2.49% | |
| JRVR | James River Group Holdings Ltd. | 3.97 | -1.93 | -32.72% |
Ryan Specialty Group Corporate Events
Ryan Specialty posts solid Q3 results despite headwinds
PositiveOn October 29, 2026, Ryan Specialty reported third-quarter 2026 results showing total revenue up 4.7% year over year to $790.0 million and an organic revenue growth rate of 4.0%, down from 15.0% a year earlier. Net income rose 40.6% to $88.0 million,...
Ryan Specialty Announces Neutral-Dilution Executive Option Agreement
PositiveOn August 4, 2026, Ryan Specialty Holdings, Inc. and the Ryan Stock Option Trust, overseen by Executive Chairman Patrick G. Ryan and Shirley W. Ryan, amended an existing Executive Chairman Option Settlement Agreement tied to the company’s 2021...
Ryan Specialty Delivers Solid Q2 Growth Amid Margin Pressure
PositiveFor the second quarter ended June 30, 2026, Ryan Specialty reported total revenue of $916.6 million, up 7.2% year over year, with organic revenue growth of 6.7% and Adjusted EBITDAC rising 6.0% to $326.9 million, while net income fell 13.1% to $108.4...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 30, 2026